Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Noel

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of the Pediatric Infectious Diseases Society|February 14, 2018
Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our ApproachGary J Noel, Sumathi Nambiar, John Bradley, et al.
Expert Opinion on Investigational Drugs|March 21, 2007
Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacyKaren Bush, Markus Heep, Mark J Macielag, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2009
Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in childrenFang Li, Partha Nandy, Shuchean Chien, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2002
Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo modelMurli U Purswani, Susan J Eckert, Harman K Arora, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 30, 2008
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infectionsGary J Noel, Karen Bush, Partha Bagchi, et al.
The Pediatric Infectious Disease Journal|August 17, 2002
Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycinChuen L Yee, Ciaran Duffy, Peter G Gerbino, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infectionsHolly Kimko, Bindu Murthy, Xu Xu, et al.
Journal of Clinical Pharmacology|April 23, 2004
Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordingsGary J Noel, Daniel B Goodman, Shuchean Chien, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infectionsGary J Noel, Michael P Draper, Howard Hait, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2007
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteriaGary J Noel, Richard S Strauss, Karen Amsler, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of the Pediatric Infectious Diseases Society|February 14, 2018
Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our ApproachGary J Noel, Sumathi Nambiar, John Bradley, et al.
Expert Opinion on Investigational Drugs|March 21, 2007
Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacyKaren Bush, Markus Heep, Mark J Macielag, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2009
Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in childrenFang Li, Partha Nandy, Shuchean Chien, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2002
Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo modelMurli U Purswani, Susan J Eckert, Harman K Arora, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 30, 2008
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infectionsGary J Noel, Karen Bush, Partha Bagchi, et al.
The Pediatric Infectious Disease Journal|August 17, 2002
Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycinChuen L Yee, Ciaran Duffy, Peter G Gerbino, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infectionsHolly Kimko, Bindu Murthy, Xu Xu, et al.
Journal of Clinical Pharmacology|April 23, 2004
Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordingsGary J Noel, Daniel B Goodman, Shuchean Chien, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infectionsGary J Noel, Michael P Draper, Howard Hait, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2007
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteriaGary J Noel, Richard S Strauss, Karen Amsler, et al.
Pageof 3